What a terribly #humiliating #phase this must be.. na?

6. Phase Markets move through recurring phases of accumulation and distribution. During accumulation, positions are built, creating structural conditions for sustained trends. During distribution, exposure is reduced, often leading to weakening trends or reversals. #ACM #phase

We are in the #stable #phase(+,+,-) of the local weather. It is calm, quiet, & peaceful. The clouds are white, fluffy, & just floating along effortlessly. #CapstoneStabilityTheorem

【Phase】 「私は、ここに存在しているらしい。」 Aimai-ish Frame Club An archive of ambiguous frames. #Phase #AimaiishFrameClub #AIart #AIイラスト #AIgirl

IS:SUE return with PHASE, a compact four-track release that sticks to their familiar structure while offering a mix of styles across its runtime. link.selective-hearing.com/issue-phase-re… #ISSUE #이슈 #PHASE #JPop #MusicReview #SelectiveHearing @issue_is_coming

@jiayihae I RETRACT WHAT I SAID they're just on a #phase

SHIB Price Prediction: Consolidation Phase Continues as Bulls Eye $0.0000065 Breakout SHIB trades sideways at $0.0000059 with neutral RSI at 49.03. Technical analysis suggests potential move to $0.0000065 resistance, bu ➤ jmpto.net/Yczio #Consolidation #Shib #Phase

SHIB Price Prediction: Consolidation Phase Continues as Bulls Eye $0.0000065 Breakout SHIB trades sideways at $0.0000059 with neutral RSI at 49.03. Technical analysis suggests potential move to $0.0000065 resistance ➤ go.bitrss.com/sbMtZ #Phase #Consolidation #Shib

🚨 Latest #Phase 3 Update! 🔷 A Phase 3 randomized trial compared transdermal estradiol (tE2) patches with LHRH agonists in men with locally advanced prostate cancer. The study demonstrated comparable 3-year metastasis-free survival (87.1% vs 85.9%; HR 0.96), meeting the predefined noninferiority margin . 🔷 Secondary outcomes included testosterone suppression, overall survival, and safety, with tE2 showing similar castration rates and fewer hot flashes but higher gynecomastia, supporting its potential as an alternative hormonal therapy option. 🔗 Read more: bit.ly/ONCOnews-26-Ma… #ONCOnews #OncoAlert #OncEd #ProstateCancer #Oncology #CancerResearch #HormoneTherapy #ClinicalTrials #Phase3Trial #MedicalResearch #CancerTreatment #Urology #Endocrinology #PrecisionMedicine #TargetedTherapy #HealthcareInnovation #Pharma #Biotech #DrugDevelopment #EvidenceBasedMedicine #SurvivalOutcomes #CancerCare #OncoTwitter #MedTwitter #MedicalScience #MedEd #HealthcareProfessionals #FutureOfMedicine

@LyricWrestling Look it was a #phase that he had to go through

@phaseforex #phase forex lisanslimi guvenilirmi kontrol etmeden bu ve benzeri firmalarda yatirim yapmayin # spk #cimer#masak

【Phase】 「人工の光が、この夜のすべてを飲み込んでいく。 私も、その一部。」 Aimai-ish Frame Club An archive of ambiguous frames. #Phase #AimaiishFrameClub #AIart #AIイラスト #AIgirl

#Phase 1 completed Proud moment of my trading journey On to the next phase 💪🏻 @GoatFunded @EdwardXLreal #GFT #goatfundedtraderlf

🚨 Latest #Phase 3 Update! 🔷 The combination of TALZENNA (talazoparib) plus XTANDI (enzalutamide) significantly improves radiographic progression-free survival in patients with metastatic prostate cancer. This highlights the potential of targeted combination therapy to delay disease progression and enhance treatment outcomes. 🔷 The combination significantly improved radiographic progression-free survival versus Enzalutamide alone, exceeding the predefined hazard ratio target of 0.63, with consistent benefit across BRCA and non-BRCA subgroups and a favorable trend toward improved overall survival. 🔗 Read more: bit.ly/ONCOnews-23-Ma… #ONCOnews #OncoAlert #OncEd #ProstateCancer #MetastaticProstateCancer #HormoneSensitiveProstateCancer #HRRMutation #PrecisionMedicine #TargetedTherapy #Oncology #CancerResearch #ClinicalTrials #Phase3Trial #OncologyNews #CancerTreatment #CancerCare #MedicalInnovation #Pharma #Biotech #PersonalizedMedicine #OncologyCommunity #MedicalScience #EvidenceBasedMedicine #MedEd #HealthcareInnovation #TranslationalMedicine #CancerTherapy #ClinicalResearch #FutureOfMedicine #GlobalHealth #ResearchMatters #Oncologist #UroOncology

🚨 Latest #Phase 3 Update! 🔷 HUTCHMED has initiated a Phase III clinical trial evaluating HMPL-760 in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). The study aims to assess the efficacy and safety of this investigational therapy in a population with significant unmet treatment needs. 🔷 Relapsed/refractory DLBCL remains a challenging setting with limited durable treatment options for many patients. The Phase III development of HMPL-760 may contribute to expanding targeted therapy strategies in aggressive lymphoma. 🔗 Read more: bit.ly/ONCOnews-23-Ma… #ONCOnews #OncoAlert #OncEd #DLBCL #Lymphoma #BloodCancer #Hematology #Oncology #CancerResearch #ClinicalTrials #Phase3Trial #TargetedTherapy #PrecisionMedicine #OncologyNews #CancerTreatment #CancerCare #MedicalInnovation #Pharma #Biotech #PersonalizedMedicine #OncologyCommunity #MedicalScience #EvidenceBasedMedicine #MedEd #HealthcareInnovation #TranslationalMedicine #CancerTherapy #ClinicalResearch #FutureOfMedicine #GlobalHealth #ResearchMatters #HemeOnc #NonHodgkinLymphoma

🚨 Latest #Phase 3 Update! 🔷 The Phase 3 BRIGHT-2 trial evaluates the efficacy of Bireociclib combined with Fulvestrant in patients with advanced breast cancer who have progressed after endocrine therapy. The study explores a targeted strategy to overcome endocrine resistance and improve progression outcomes. 🔷 The combination significantly improved progression‑free survival (14.7 vs 7.3 months; HR 0.54) and objective response rates (45.6% vs 14.9%), supporting its potential to extend disease control in this setting. 🔷 Findings from BRIGHT-2 provide important insights into combination therapy approaches for HR+ advanced breast cancer following endocrine progression. 🔗 Read more: bit.ly/ONCOnews-23-Ma… #ONCOnews #OncoAlert #OncEd #BreastCancer #AdvancedBreastCancer #HRPositive #Oncology #CancerResearch #ClinicalTrials #Phase3Trial #TargetedTherapy #PrecisionMedicine #EndocrineTherapy #CancerTreatment #OncologyNews #MedicalInnovation #OncologyCommunity #CancerCare #CancerAwareness #HealthcareInnovation #Pharma #Biotech #TranslationalMedicine #EvidenceBasedMedicine #MedEd #Oncologist #MedicalScience #GlobalHealth #ResearchMatters #FutureOfMedicine #CancerTherapy #ClinicalResearch #PersonalizedMedicine

#APM #Terminals invests in major #Phase #III #expansion at #Lázaro #Cárdenas container-news.com/apm-terminals-…